| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 6,606.38 | 17,991.31 | 14,881.20 | 12,546.24 |
| Accumulated Depreciation Total | -1,048.76 | -880.89 | -3,002.13 | -2,565.62 |
| Cash Equivalents | 47.07 | 77.60 | 358.68 | - |
| Other Liabilities Total | 100.30 | 288.83 | 660.69 | 396.79 |
| Accrued Expenses | 6.40 | 2.19 | 2.02 | 1.22 |
| Long Term Debt | 483.71 | 446.08 | 1,312.30 | 1,466.40 |
| Common Stock Total | 499.52 | 499.52 | 499.52 | 499.51 |
| Other Equity Total | 375.33 | 777.70 | 748.38 | 612.10 |
| Other Current Assets Total | 25.35 | 13,622.00 | 465.03 | 144.57 |
| Prepaid Expenses | 16.84 | 16.58 | 142.89 | 113.93 |
| Total Assets | 6,606.38 | 17,991.31 | 14,881.20 | 12,546.24 |
| Current Portof LT Debt/ Capital Leases | 163.58 | 140.07 | 733.27 | 677.20 |
| Additional Paid- In Capital | 2,230.61 | 2,222.41 | 2,219.17 | 2,200.46 |
| Cash | 117.52 | 4.63 | 19.85 | 343.37 |
| Total Equity | 3,428.07 | 4,559.79 | 4,448.07 | 3,953.41 |
| Long Term Investments | 254.56 | 13.74 | 68.30 | 38.19 |
| Retained Earnings( Accumulated Deficit) | -17.72 | 1,071.13 | 994.49 | 643.63 |
| Treasury Stock- Common | -8.23 | -10.97 | -13.49 | -2.29 |
| Total Common Shares Outstanding | 49.82 | 49.78 | 49.74 | 49.72 |
| Property/ Plant/ Equipment Total- Gross | 4,967.33 | 3,930.80 | 10,805.75 | 9,205.99 |
| Tangible Book Valueper Share Common Eq | 62.90 | 85.67 | 58.72 | 52.04 |
| Goodwill Net | 264.12 | 264.12 | 1,159.67 | 1,087.91 |
| Total Liabilities | 3,178.31 | 13,431.52 | 10,433.13 | 8,592.83 |
| Total Debt | 2,017.77 | 1,383.75 | 5,700.30 | 4,907.13 |
| Short Term Investments | 1,196.50 | 23.80 | 17.94 | 26.11 |
| Cashand Short Term Investments | 1,361.09 | 106.03 | 396.47 | 369.48 |
| Total Receivables Net | 384.12 | 283.12 | 2,504.70 | 2,402.28 |
| Notes Payable/ Short Term Debt | 24.89 | 107.20 | 500.32 | 290.61 |
| Deferred Income Tax | 146.12 | 247.63 | 238.06 | 168.93 |
| Accounts Receivable- Trade Net | 326.97 | 264.64 | 2,388.60 | 2,060.87 |
| Property/ Plant/ Equipment Total- Net | 3,918.57 | 3,049.95 | 7,803.62 | 6,640.37 |
| Minority Interest | 223.38 | 470.32 | 412.39 | 529.21 |
| Total Current Liabilities | 879.21 | 11,288.26 | 4,655.28 | 3,558.58 |
| Total Inventory | 114.07 | 137.57 | 1,412.47 | 1,066.20 |
| Accounts Payable | 426.20 | 458.70 | 2,987.77 | 2,118.09 |
| Other Currentliabilities Total | 258.14 | 10,580.10 | 431.90 | 471.46 |
| Total Long Term Debt | 1,829.30 | 1,136.48 | 4,466.71 | 3,939.32 |
| Intangibles Net | 30.32 | 31.38 | 368.08 | 278.09 |
| Other Long Term Assets Total | 78.24 | 118.53 | 185.48 | 142.37 |
| Note Receivable- Long Term | 159.10 | 348.29 | 374.49 | 262.85 |
| Unrealized Gain( Loss) | 348.56 | - | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,901.47 | 14,165.30 | 4,921.56 | 4,096.46 |
| Capital Lease Obligations | 1,345.59 | 690.40 | 3,154.41 | 2,472.92 |
Aster DM Healthcare Dividend Aster DM Healthcare Bonus Aster DM Healthcare News Aster DM Healthcare AGM Aster DM Healthcare Rights Aster DM Healthcare Splits Aster DM Healthcare Board Meetings Aster DM Healthcare Key Metrics Aster DM Healthcare Shareholdings Aster DM Healthcare Profit Loss Aster DM Healthcare Cashflow Aster DM Healthcare Q1 Results Aster DM Healthcare Q2 Results Aster DM Healthcare Q3 Results Aster DM Healthcare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks